nmsg

Nerviano Medical Sciences to present data on novel anticancer molecules at the AACR Annual Meeting 2012

Nerviano, Mar 1, 2012. – Nerviano Medical Sciences will disclose data on novel anticancer molecules at the AACR Annual Meeting 2012.

The presentations include:

Magnaghi, P et al: “Identification of potent VCP/p97/CDC48 inhibitors with distinct biochemical mechanisms including a reversible, allosteric inhibitor that activates the unfolded protein response, induce autophagy and cancer cell death”. Oral presentation. Abstract Number:  2940 Presentation Time: Monday, Apr 02, 2012, 3:20 PM - 3:35 PM

Pulici, M et al: “Characterization of NMS-P285, a new highly selective and potent BRAF inhibitor”. Abstract Number:  3754. Presentation Time: Tuesday, Apr 03, 2012, 8:00 AM -12:00 PM 

Montagnoli, A et al: “Characterization of new highly selective and potent PARP-1 inhibitors”. Abstract Number:  1775. Presentation Time: Monday, Apr 02, 2012, 8:00 AM -12:00 PM 
 
Per offrirti un'esperienza di navigazione ottimizzata NMS Group e le società controllate utilizzano cookies, anche di terze parti.
Proseguendo con la navigazione acconsenti al loro impiego in conformità della nostra  
Cookie Policy.